CAROLINE MESSER: Open Payments
NPI 1386855047 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,821 in 120 payments from 24 companies in 2025. Trend: 2023 $3,914 · 2024 $3,259 · 2025 $2,821
Food & beverage: $2,821
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $370 |
| Lilly USA, LLC | 18 | $367 |
| Mannkind Corporation | 12 | $309 |
| Amgen Inc. | 12 | $244 |
| ABBVIE INC. | 10 | $187 |
| SANOFI-AVENTIS U.S. LLC | 7 | $179 |
| Astellas Pharma US Inc | 7 | $173 |
| Antares Pharma, Inc. | 7 | $143 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $128 |
Products named: AFREZZA, MOUNJARO, Wegovy, Ozempic, TZIELD, Veozah, EVENITY, XYOSTED.
Industry payments across NY — which companies pay providers there.
